Archive
US stocks close higher on vaccine optimism as Biden taps ex-Fed Chair Yellen as Treasury secretary
Yellen headed the Fed from 2014 to 2018 when the S&P 500 rose nearly 60%
Company
Pfizer Inc
NYSE:PFE
Pfizer Inc is a research-based biopharmaceutical company. The company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operates through two segments: Biopharma and PC1.
293 stories · page 7 of 15
Pfizer, Moderna COVID-19 vaccine candidates may get EU approval in December
Pfizer and BioNTech have submitted an application to the US authorities for emergency approval on Friday
BetterLife says its AP-003 coronavirus treatment has similarities with Pfizer's vaccine
AP-003 and the Pfizer vaccine both utilize interferons, which are a natural part of the body’s innate immune system but that are blocked by the coronavirus
Pfizer now says COVID-19 vaccine is 95% effective and can be ready in days
On Monday, rival Moderna released data showing its rival candidate had achieved 94.5% effectiveness
Archive
US stocks close down sharply after sell-off in final minutes amid rising coronavirus cases
Stocks tanked despite Pfizer's announcement Wednesday that its vaccine was 95% effective in preventing COVID-19
Archive
FTSE 100 closes higher as vaccine hopes continue to cheer; sterling firms
Britain's blue-chip benchmark closed ahead by nearly 20 points at 6,385, while FTSE 250 added over 183 points at 19,699
Moderna’s COVID-19 vaccine candidate can be stored at warmer temperatures than Pfizer’s, easing distribution
The ultra-cold temperatures needed by Pfizer's jab may be a significant hurdle for its distribution
Oil rallies on vaccine hopes but demand seen continuing to fall for rest of year
In Friday trading, Brent crude was above US$43 with WTI over US$40 a barrel
Stock rotation after Pfizer’s positive vaccine news may have gone too far
The world is likely to need diagnostics and treatment for many more months, even after jabs start to be rolled out
Coronavirus: Russia says Sputnik V vaccine effective in 92% of cases
The Kremlin is planning to roll out the jab in the coming weeks
Malcy's Blog - Far Limited and Jadestone Energy
Far Limited (ASX:FAR) Far has announced a SPA with ONGC for their PSC offshore Senegal for $45m plus working cap since 1 Jan of $66.58m. The offer, whilst looking lower than might have been expected a while ago ‘represents the best option a
US stocks close mixed session as investors rotate out of technology and stay-at-home stocks
Investors are shifting into cyclical stocks that benefit from a recovering economy
Archive
Today's Market View - Bushveld Minerals; Endeavour Mining; Thor Mining and more...
Economics China – Credit growth slowed in October reflecting lower issuance of government bonds and seasonal factors in October as businesses were shut because of public holidays. Aggregate Financing (CNY bn): 1,420 v 3,477 in September and
Which Covid vaccine candidates are competing against Pfizer?
The US firm and partner BioNTech are just about to submit their jab to the US authorities. Who else is almost there?
Pfizer to submit COVID-19 vaccine candidate for emergency use authorisation next week after positive late-stage trial data
The jab was found to be effective in over 90% of cases while there were no safety concerns
Archive
Dow closes up more than 800 points on vaccine news, Biden win
Earlier today, Pfizer reported its vaccine candidate was 90% effective in phase III clinical trials, sending market sentiment sky high
Pfizer hopes to produce 100mln COVID-19 vaccine doses before 2021
The candidate is expected to be ready for submission to the authorities in the third week of November
Archive
US stocks end mixed as DJIA notches first daily gain in four sessions on strong US consumer data
The data showed US retail sales rose 1.9% month, well ahead of estimates of around 0.6%
Archive
US stocks close sharply lower after Trump calls off stimulus talks until after the election
The airlines are under pressure as the industry is hinging on additional aid to avoid more layoffs
Pfizer reports moderate side effects in COVID-19 vaccine trials
The independent data monitoring committee reviewing the study did not express safety concerns